PSORIASIS

Psorijaza je kronično-recidivirajuća upalna bolest kože od koje u svijetu boluje 2 – 3%, a u Hrvatskoj oko 1,6% pučanstva. Danas se psorijaza smatra upalnom multisustavnom bolesti koja uz kožu može zahvatiti i brojne druge organske sustave u obliku razvoja komorbiditeta poput hipertenzije, dijabetesa, kardiovaskularnih bolesti, upalnih bolesti crijeva i oka te psihosocijalnih komorbiditeta. Najčešći komorbiditet u psorijazi jest psorijatični artritis koji zahvaća 30 – 40% bolesnika, iako točni epidemiološki podatci nisu poznati. Nova paradigma poimanja psorijaze i psorijatičnog artritisa danas govori da je riječ o psorijatičnoj bolesti koja ima kožne i/ili muskuloskeletne manifesta cije. Suvremeno liječenje psorijaze temeljeno na dokazima uključuje kliničko iskustvo, znanstvene dokaze, ali i želje pacijenata prilikom odabira odgovarajuće terapije. Biološka terapija u liječenju psorijaze znatan je napredak u odnosu prema klasičnoj terapiji psorijaze zbog visoke učinkovitosti i dobre sigurnosti novih lijekova.Psoriasis is a chronic infl ammatory skin disease aff ecting about 2-3% of the world population, and around 1.6% of the population in Croatia. Nowadays, psoriasis is considered to be a multisystemic infl ammatory disease with a variety of comorbidities such as hypertension, diabetes, cardiovascular diseases, infl ammatory bowel and eye diseases, and psychosocial comorbidities. Th e most common comorbidity in psoriasis is psoriatic arthritis, aff ecting about 30-40% of patients, although accurate epidemiological data are not available. Nowadays, the new paradigm of psoriasis and psoriatic arthritis uses the term psoriatic disease with skin and/or musculoskeletal manifestations. Contemporary treatment of psoriasis relies on evidence-based medicine including clinical experience, scientifi c evidence, but also patients’ desires when choosing the appropriate therapy. Biological therapy in the treatment of psoriasis represents a signifi cant progress compared to classical psoriasis therapy, due to the high effi cacy and safety of new drugs

PSORIASIS

Psorijaza je kronično-recidivirajuća upalna bolest kože od koje u svijetu boluje 2 – 3%, a u Hrvatskoj oko 1,6% pučanstva. Danas se psorijaza smatra upalnom multisustavnom bolesti koja uz kožu može zahvatiti i brojne druge organske sustave u obliku razvoja komorbiditeta poput hipertenzije, dijabetesa, kardiovaskularnih bolesti, upalnih bolesti crijeva i oka te psihosocijalnih komorbiditeta. Najčešći komorbiditet u psorijazi jest psorijatični artritis koji zahvaća 30 – 40% bolesnika, iako točni epidemiološki podatci nisu poznati. Nova paradigma poimanja psorijaze i psorijatičnog artritisa danas govori da je riječ o psorijatičnoj bolesti koja ima kožne i/ili muskuloskeletne manifesta cije. Suvremeno liječenje psorijaze temeljeno na dokazima uključuje kliničko iskustvo, znanstvene dokaze, ali i želje pacijenata prilikom odabira odgovarajuće terapije. Biološka terapija u liječenju psorijaze znatan je napredak u odnosu prema klasičnoj terapiji psorijaze zbog visoke učinkovitosti i dobre sigurnosti novih lijekova.Psoriasis is a chronic infl ammatory skin disease aff ecting about 2-3% of the world population, and around 1.6% of the population in Croatia. Nowadays, psoriasis is considered to be a multisystemic infl ammatory disease with a variety of comorbidities such as hypertension, diabetes, cardiovascular diseases, infl ammatory bowel and eye diseases, and psychosocial comorbidities. Th e most common comorbidity in psoriasis is psoriatic arthritis, aff ecting about 30-40% of patients, although accurate epidemiological data are not available. Nowadays, the new paradigm of psoriasis and psoriatic arthritis uses the term psoriatic disease with skin and/or musculoskeletal manifestations. Contemporary treatment of psoriasis relies on evidence-based medicine including clinical experience, scientifi c evidence, but also patients’ desires when choosing the appropriate therapy. Biological therapy in the treatment of psoriasis represents a signifi cant progress compared to classical psoriasis therapy, due to the high effi cacy and safety of new drugs

PSORIASIS

Psorijaza je kronično-recidivirajuća upalna bolest kože od koje u svijetu boluje 2 – 3%, a u Hrvatskoj oko 1,6% pučanstva. Danas se psorijaza smatra upalnom multisustavnom bolesti koja uz kožu može zahvatiti i brojne druge organske sustave u obliku razvoja komorbiditeta poput hipertenzije, dijabetesa, kardiovaskularnih bolesti, upalnih bolesti crijeva i oka te psihosocijalnih komorbiditeta. Najčešći komorbiditet u psorijazi jest psorijatični artritis koji zahvaća 30 – 40% bolesnika, iako točni epidemiološki podatci nisu poznati. Nova paradigma poimanja psorijaze i psorijatičnog artritisa danas govori da je riječ o psorijatičnoj bolesti koja ima kožne i/ili muskuloskeletne manifesta cije. Suvremeno liječenje psorijaze temeljeno na dokazima uključuje kliničko iskustvo, znanstvene dokaze, ali i želje pacijenata prilikom odabira odgovarajuće terapije. Biološka terapija u liječenju psorijaze znatan je napredak u odnosu prema klasičnoj terapiji psorijaze zbog visoke učinkovitosti i dobre sigurnosti novih lijekova.Psoriasis is a chronic infl ammatory skin disease aff ecting about 2-3% of the world population, and around 1.6% of the population in Croatia. Nowadays, psoriasis is considered to be a multisystemic infl ammatory disease with a variety of comorbidities such as hypertension, diabetes, cardiovascular diseases, infl ammatory bowel and eye diseases, and psychosocial comorbidities. Th e most common comorbidity in psoriasis is psoriatic arthritis, aff ecting about 30-40% of patients, although accurate epidemiological data are not available. Nowadays, the new paradigm of psoriasis and psoriatic arthritis uses the term psoriatic disease with skin and/or musculoskeletal manifestations. Contemporary treatment of psoriasis relies on evidence-based medicine including clinical experience, scientifi c evidence, but also patients’ desires when choosing the appropriate therapy. Biological therapy in the treatment of psoriasis represents a signifi cant progress compared to classical psoriasis therapy, due to the high effi cacy and safety of new drugs

Perceived Effects of Croatian Customs Services Reform: the Opinion of Forwarders from Istarska County

The reforms of the public sector rank among the most complex problems Croatia has to face in the process of transition and accession to the EU. One of the recent reforms, the Customs Service Reform, offers insights into some of the achieved improvements and may serve as a guideline for reformers in other areas of public management. This research provides evidence of “customer satisfaction” with the functioning of the Croatian Customs System. Conclusions have been drawn based on the responses of 31 forwarders from Istarska County using a 19-item Likert scale. According to their opinion, services have improved in several aspects during the past few years, and accordingly the results can be interpreted as an indication of success of reform efforts

The mediating role of hotel employees’ job satisfaction and performance in the relationship between authentic leadership and organizational performance

Authentic leadership is a positive leadership theory, conceptualized under the influence of positive psychology and positive organizational behaviour movement. Although it has become a recognized leadership theory, it is still somewhat neglected in the hospitality literature. To address this gap, the paper seeks to develop and test a conceptual model linking authentic leadership to organizational performance in the hospitality context. Hypotheses were tested using hierarchical multiple regression analysis on a sample of 226 employees from 24 hotels in Croatia. The research results confirmed the positive impact of authentic leadership on hotels’ operational performance, which was mediated by followers’ job satisfaction and performance. There was no empirical support for the hypothesized impact of authentic leadership on hotels’ financial performance. The findings suggest that authentic leadership behaviours, together with positive organisational settings, characterized by flexible organizational structure, are more likely to enhance desirable employees’ attitudes and behaviours, resulting in improved organizational performance

Discussions on Chemistry Terminology in the Journal Chemistry Archive

U uvodnom dijelu rada prikazan je ukratko razvoj hrvatskoga kemijskoga nazivlja, što se naročito počelo poticati u drugoj polovici 19. stoljeća u skladu s ciljevima hrvatskoga narodnog preporoda i s razvojem prirodnih znanosti. Prikazane rasprave o kemijskom nazivlju i imenima spojeva u razdoblju 1927–1953. pokazuju kako u tom razdoblju unatoč dugogodišnjim nastojanjima nije postignuta suglasnost. Pred hrvatskim je kemičarima zadaća da u suradnji s hrvatskim jezikoslovcima izrade vlastiti strukovni jezik.The introductory part of the paper presents a brief outline of the development of the Croatian chemistry terminology, which was particularly encouraged in the second half of the 19th century, in accordance with the objectives of the Croatian National Revival and the development of natural sciences. The discussions on chemistry terminology and the classification of compounds (nomenclature) in the period 1927-1953 show that despite years long efforts, no agreement was reached in that period. The Croatian chemists, working together with the Croatian linguists, have before them the task of formulating their own register